Meet Our Board
Mr. Gorevic is chief executive officer of Teladoc Health and has been a member of the board of directors since June 2009.
Under Mr. Gorevic’s visionary leadership, Teladoc Health has continued to set the bar in the virtual delivery of care, achieving unprecedented milestones and defining the market. He is responsible for driving the growth and innovation strategies that have led to transformative results for Teladoc Health’s members, clients, partners, employees, and shareholders. He took the company public in 2015, and has grown it to more than $200 million in revenue in 2017. Under his leadership the company has established a proven track record of driving healthcare transformation by executing on the corporate strategic vision, delivering award-winning innovation, and effectively integrating each corporate acquisition.
Prior to joining Teladoc Health, Mr. Gorevic served in various management roles at WellPoint, Inc. (now Anthem, Inc.), including president of Empire BlueCross BlueShield and senior vice president and chief sales and product officer.
From 2002 to 2005, Mr. Gorevic was a member of Empire BlueCross BlueShield’s leadership team, as chief sales and marketing officer. From July 2000 to December 2001, Mr. Gorevic served as chief executive officer of Gemfinity, an electronic marketplace and purchasing aggregator that he founded. From July 1999 to July 2000, he served as general manager of business messaging at Mail.com, Inc., a provider of internet messaging services, and from April 1998 to June 1999, he served as Mail.com’s vice president of operations.
Mr. Gorevic is a nationally recognized thought leader and trailblazer in virtual healthcare delivery. Prior to joining Teladoc Health, he held various executive leadership roles at WellPoint, Inc. (now Anthem, Inc.), Empire BlueCross BlueShield, Oxford Health, Mail.com, and Gemfinity.
He is a member of the board of directors of the New York Road Runners and serves on its youth and community service committee.
David B. Snow, Jr.
Mr. Snow became a member of our board of directors in February 2014 and later was named chairman of our board in December 2014.
Since February 2014, Mr. Snow has served as chairman and chief executive officer of Cedar Gate Technologies, Inc., a provider of analytic and information technology services to doctor and hospital organizations entering risk-based reimbursement arrangements with insurers. Until April 2012, Mr. Snow was chairman and chief executive officer of Medco Health Solutions, Inc., a leading pharmacy benefit manager. His current board service includes CareCentrix (since 2014) and Pitney Bowes, Inc. (since 2006). He formerly served as a director of Medco Health Solutions, Inc.
In addition to his experience as the chief executive officer of a public company, Mr. Snow has a strong background in operations, having served in leadership positions at several companies including WellChoice (Empire Blue Cross Blue Shield) and Oxford Health Plans. Mr. Snow earned a Bachelor of Science in economics from Bates College and a master’s degree in healthcare administration from Duke University.
Mr. Chris Bischoff became a member of the Teladoc Health board of directors in November 2020.
Mr. Bischoff is the senior investment director of Kinnevik, a leading European investment company with over $12 billion of assets. Kinnevik invests in technology-enabled companies at the venture and growth stages in the telecoms, consumer, financial and healthcare services sectors. Mr. Bischoff leads the investment team, overseeing all the sectors, with a focus on healthcare transformation in Europe and the U.S.
Mr. Bischoff also serves on the board of Betterment, Cityblock Health and VillageMD. Prior board roles include Avito, Babylon Health, Cedar Cares and Livongo.
Before joining Kinnevik, Mr. Bischoff was a managing director of Goldman Sachs in Europe, where he led the media and technology investment banking team. Mr. Bischoff is based in Kinnevik’s London office.
Karen L. Daniel
Ms. Karen L. Daniel became a member of the Teladoc Health board of directors in November 2020.
Ms. Daniel retired in July 2018 as executive director, division president and chief financial officer of the Global Finance and Technology Solutions division for Black & Veatch, a global leader in providing engineering, consulting and construction services for energy, water, and telecommunication sectors.
As CFO, she was responsible for leading the company’s global financial operations that included treasury, tax, accounting, financial reporting, budgeting and financial systems, and establishing corporate financial policies. Ms. Daniel also led the company’s global IT organization, which included oversight of systems, technology development and associated service providers.
Ms. Daniel currently serves on the boards of directors of publicly traded Commerce Bancshares Inc. and Snap-On Incorporated. In 2020, she completed a three-year term on the board of Blue Cross and Blue Shield of Kansas City. She is also the past chairwoman of the Greater Kansas City Chamber of Commerce. She holds a Bachelor of Science degree in accounting from Northwest Missouri State University and a Master of Science degree in accounting from the University of Missouri-Kansas City.
Ms. Sandra Fenwick became a member of the Teladoc Health board of directors in November 2020.
Ms. Fenwick is the chief executive officer of Boston Children’s Hospital, where she leads the nation’s foremost independent pediatric hospital and the world’s leading center of pediatric medical and health research. She has been a driving force to improve the effectiveness and efficacy of the care provided at Boston Children’s, while at the same time reducing the cost of care. Ms. Fenwick joined Boston Children’s in 1999 as senior vice president and was appointed chief operating officer that year. She was named president in 2008 and was appointed chief executive officer in 2013.
Ms. Fenwick currently serves on the boards of directors of Harvard’s Wyss Institute for Biologically Inspired Engineering; Children’s Hospital Association; Greater Boston Chamber of Commerce; CRICO, Ltd.; CRICO Vermont and Boston Children’s Hospital. She is also a member of the Massachusetts Women’s Forum and Women Corporate Directors Boston. She holds a bachelor’s degree from Simmons College with distinction and a master’s in Public Health degree in Health Services Administration from the University of Texas School of Public Health. She has received numerous awards and honorary degrees for her contributions to healthcare.
William H. Frist, M.D.
U.S. Sen. William Frist became a member of our board of directors in September 2014.
Since 2007, Sen. Frist has served as a partner in Cressey & Company, a private investment firm focused exclusively on growing emerging health care businesses. He served as U.S. Senator for Tennessee from 1995 to 2007 and was majority leader of the Senate from 2003 to 2007, participating in the debate and development of major public policy issues and health legislation. Prior to the Senate, Sen. Frist spent 20 years in clinical medicine, completing surgical training at Harvard’s Massachusetts General Hospital and at Stanford; he subsequently founded the Vanderbilt Multi-Organ Transplant Center. Sen. Frist serves as an adjunct professor of cardiac surgery at Vanderbilt University and clinical professor of surgery at Meharry Medical College.
Sen. Frist currently serves as a member of the board of the publicly held companies Select Medical and AECOM. In addition, he serves as a board member for several of Cressey & Company’s privately held portfolio companies. He previously served as a director of URS Corporation from November 2009 to 2014, and on the board of Third National Bank from 1990 to 1994.
Sen. Frist serves on the boards of several other organizations, including the Center for Strategic and International Studies, Partnership for a Healthier America, Hope Through Healing Hands, the Kaiser Family Foundation, the Robert Wood Johnson Foundation, the Nashville Health Care Council and the Harvard Medical School Board of Fellows.
He is a senior fellow at the Bipartisan Policy Center, where he is co-leader of the Health Project. Sen. Frist earned a Bachelor of Arts from Princeton University and an M.D. from Harvard Medical School.
Ms. Jacobson became a member of our board of directors in February 2020.
She is the president and CEO of Froedtert Health, a regional health care system based in Milwaukee, Wisconsin. Before joining Froedtert Health, Ms. Jacobson spent 22 years at Rush University Medical Center in Chicago in various executive leadership roles, leaving the corporation as chief financial officer, treasurer and SVP of finance and strategic planning, marketing and communication.
A former board member and national chair of the Healthcare Financial Management Association (HFMA), Ms. Jacobson is also an active member of the American College of Healthcare Executives and Healthcare Institute, and previously served as chair of the board of the Wisconsin Hospital Association.
In 2019, *Modern Healthcare* recognized her as one of the 100 Most Influential People in Healthcare, while Junior Achievement of Wisconsin named her one of its 2018 Distinguished Executive of the Year, inducting her into the Wisconsin Business Hall of Fame. A graduate of Bradley University, Ms. Jacobson was recently awarded the honorary degree of Doctor of Healthcare Leadership from the University of Wisconsin-Milwaukee.
Thomas G. McKinley
Mr. McKinley became a member of our board of directors in November 2009.
Mr. McKinley, who has more than 35 years of investment experience, is a general partner and the West Coast representative for Cardinal Partners, a venture capital firm focused exclusively on healthcare investing. Prior to joining Cardinal, Mr. McKinley was the co-founder and co-managing partner of Partech International. Mr. McKinley currently serves on the board of directors of lifeIMAGE, a cloud-based medical imaging sharing platform for hospitals, physicians, and patients.
In addition, Mr. McKinley is the founding chief executive officer and director of Cardinal Analytx, a software startup spun out of Stanford University that was created to identify and target high-cost patients for early medical interventions. Mr. McKinley earned Bachelor of Arts in economics from Harvard University, a Master of Science in accounting from New York University and a Master of Business Administration from the Stanford Graduate School of Business.
Kenneth H. Paulus
Mr. Paulus became a member of our board of directors in February 2017.
From 2009 to 2014, Mr. Paulus was President and CEO of Allina Health, one of the nation’s largest not-for-profit integrated delivery systems consisting of nearly 1,500 employed physicians, 13 acute care hospitals, a freestanding emergency department, and more than 100 ambulatory care clinics. Prior to his appointment as CEO, he served as President and Chief Operating Officer of Allina Health. Before joining Allina, Mr. Paulus was the President and CEO of Atrius Health, one of the largest integrated physician organizations in New England and a teaching and research affiliate of Harvard Medical School. He also served as the Chief Operating Officer of Boston-based Partners Community HealthCare, a teaching affiliate of Harvard Medical School that includes Massachusetts General Hospital and Brigham and Women’s Hospital.
Mr. Paulus is an executive advisor at Water Street Healthcare Partners, a private investment firm, and currently serves on the board of Healthgrades. Mr. Paulus received his Master of Healthcare Administration from the University of Minnesota, and a Bachelor of Arts in biology from Augustana College.
David L. Shedlarz
Mr. Shedlarz became a member of our board in September 2016.
He is the former vice chairman, executive vice president, and chief financial officer of Pfizer, Inc., having had worldwide responsibility for the company’s former Medical Technology Group. During his 31-year tenure at Pfizer, Mr. Shedlarz played a key role in shaping the strategic direction that drove the company’s impressive growth and helped establish it as an industry leader and innovator. Among his senior leadership roles were that of executive vice president beginning in 1999, and then vice chairman in 2005, serving until his retirement in 2007.
In addition to the Teladoc Health board, Mr. Shedlarz also sits on the boards of The Hershey Company, Pitney Bowes, Inc., and the Teachers Insurance and Annuity Association of America. He holds a Master of Business Administration in finance and accounting from New York University's Leonard N. Stern School of Business, and a Bachelor of Science in economics and mathematics from Michigan State University–Oakland.
Mark D. Smith, MD, MBA
Dr. Mark Smith became a member of our board of directors in 2018.
He is a professor of clinical medicine at the University of California at San Francisco as well as a visiting professor at the School of Public Health at UC Berkeley. He is a board-certified internist and maintains a clinical practice in HIV care at San Francisco General Hospital. A nationally recognized care delivery and health policy expert, Dr. Smith is current co-chair of the Guiding Committee of the Health Care Payment Learning & Action Network, a public-private partnership launched by the U.S. Department of Health and Human Services. The group promotes the transition to value-based payment to improve care quality while lowering costs.
From 1996 through 2013 he served as the founding president and CEO of the California Health Care Foundation, an independently endowed philanthropy that works to improve healthcare access and quality for Californians. He helped build the foundation into a recognized leader in delivery system innovation, public reporting of care quality, and applications of new technology in healthcare.
Dr. Smith was formerly executive vice-president of the Henry J. Kaiser Family Foundation. He was elected to the Institute of Medicine and chaired the IOM’s Committee on The Learning Health Care System in America. He serves on the boards of the Institute for Healthcare Improvement and the Commonwealth Fund and is on the editorial board of *Health Affairs*. He received his BA from Harvard College, his MD from the University of North Carolina at Chapel Hill, and his MBA from the Wharton School at the University of Pennsylvania.
Taneja became a member of the Teladoc Health board of directors in November 2020.
Mr. Taneja is a managing director at General Catalyst. He joined the firm in 2001 and launched its Silicon Valley office in 2011. Hemant’s investment thesis, known as “economies of unscale,” describes the belief that small, tightly focused companies can leverage web services, datasets, and AI to successfully launch and compete against much larger, more established competitors.
His current investment portfolio ranges across several industries and includes companies such as Anduril, Applied Intuition, Color, Fundbox, Grammarly, Gusto, Livongo, Samsara, Snap, Stripe, and ThoughtSpot. In addition to his investments, Mr. Taneja serves on the Stanford School of Medicine Board of Fellows, is the co-founder of Advanced Energy Economy, an
organization focused on transforming energy policy in America and is a board member of Khan Lab School, a non-profit educational organization.
He teaches a course on AI, Entrepreneurship and Society at Stanford University and is a published author of two books, UnHealthcare: A Manifesto for Health Assurance and Unscaled: How AI and a New Generation of Upstarts Are Creating the Economy of the Future.
Mr. Glen Tullman became a member of the Teladoc Health board of directors in November 2020.
Mr. Tullman is the founder, former executive chairman and chief executive officer of Livongo Health. In his final year, he led Livongo through the largest consumer digital health initial public offering in history, a secondary offering, a convertible debt offering that raised over $550 million, and the industry’s largest merger to date between Livongo and Teladoc Health. He is also a founding partner at 7wireVentures, one of the highest-returning venture capital funds in Illinois.
Previously, Mr. Tullman was chief executive officer of Allscripts, the leading provider of electronic prescribing, practice management and electronic health records. He led the Allscripts IPO and secondary offering.
Mr. Tullman is dedicated to finding a cure for diabetes and other chronic conditions—and to keeping people healthy until these cures are found. In 2019, he was honored with a Robert F. Kennedy Human Rights Ripple of Hope Award for his career focused on improving the safety, empathy and efficiency of our healthcare system. Mr. Tullman serves as a chancellor to the International Board of the Juvenile Diabetes Research Foundation and as a board member of the American Diabetes Association. He has three amazing children that inspire him every day.